Vanderbilt Institute for Clinical and Translational Research (VICTR) Archive — Page 1 of 7

September 7, 2026

REDCap adds generative AI tools, with human oversight built in

Institutions were advised to connect REDCap to their own institutionally managed, secure generative AI service.

By Paul Govern
August 4, 2026

Research that reaches patients: A conversation with Wesley Self and Jill Pulley

Research and art both approach the world with a fresh perspective. This art gallery features work by undergraduate student artists who participated in the Vanderbilt Institute for Infection, Immunology and Inflammation Artist-in-Residence (VI4-AiR) program. Supported by the Burroughs Wellcome Fund, the VI4-AiR program brings together scientists and artists to create and promote art as a visual science communication tool.

June 5, 2026

New research: Heart drug may also limit the spread of cancer

For the past 20 years, Vanderbilt Health researchers have been studying ifetroban for its potential to treat conditions ranging from fibrotic lung disease to heart failure in patients with Duchenne muscular dystrophy.

By Bill Snyder
May 26, 2026

Learning Health System holds seventh annual symposium 

By Susan Urmy
April 20, 2026

Drug lifts ‘brain fog’ from lupus patients: Clinical trial

An estimated 200,000 people in the United States have lupus. About 80% of them experience “brain fog,” cognitive problems that impair learning, memory and attention. The EG501 study was the inaugural project of Vanderbilt Health’s Drug Repurposing program.

By Bill Snyder
March 27, 2026

2026 REDCap Fest recordings available online

Videos and slides from REDCap Fest 2026, held online March 4-6, are available for viewing by members of the Vanderbilt and Meharry Medical College community.

By Paul Govern